NASDAQ:ROIV

Roivant Sciences Stock Insider Trading

etoro logo Buy ROIV
*Your capital is at risk
$31.25
-0.180 (-0.573%)
At Close: Jun 22, 2026

Roivant Sciences Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -82.45. In total, the insiders bought 21.24M and sold 13.61M ROIV shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-82.45
Buy 21.24M shares
Sell 13.61M shares
45% Buy Activity
Weak Negative Correlation
Buy Signal Low Confidence
Mar 30, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -82.45.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Mar 30, 2026
Sell
Common Shares
F-InKind
Sukhatme Mayukh
President & Cio
CEO / President 29 809
Value: $787.3K
Mar 30, 2026
Buy
Capped Value Appreciation Rights
M-Exempt
Gline Matthew
CEO
CEO / President 2 178 150
Value: $57.5M
Mar 30, 2026
Buy
Common Shares
M-Exempt
Gline Matthew
CEO
CEO / President 97 319
Value: $1.23M
Mar 26, 2026
Buy
Common Shares
M-Exempt
Fitzgerald Meghan
Director
Director 70 000
Value: $616.0K
Mar 26, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Fitzgerald Meghan
Director
Director 70 000
Value: $616.0K
Mar 26, 2026
Sell
Common Shares
S-Sale
Fitzgerald Meghan
Director
Director 70 000
Value: $1.92M
Mar 20, 2026
Sell
Common Shares
F-InKind
Pulik Richard
CFO
C-Suite Officer 1 546
Value: $42.8K
Mar 20, 2026
Sell
Common Shares
F-InKind
Humes Jennifer
Chief Accounting Officer
Officer 14 526
Value: $402.4K
Mar 17, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Venker Eric
President & Immunovant CEO
CEO / President 200 000
Value: $770.0K
Mar 17, 2026
Buy
Common Shares
M-Exempt
Venker Eric
President & Immunovant CEO
CEO / President 200 000
Value: $770.0K
Mar 17, 2026
Sell
Common Shares
S-Sale
Venker Eric
President & Immunovant CEO
CEO / President 200 000
Value: $5.65M
Mar 16, 2026
Sell
Common Shares
S-Sale
Epperly Melissa B,
Director
Director 41 861
Value: $1.20M
Feb 23, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Torti Frank
President And Vant Chair
CEO / President 587 390
Value: $2.26M
Feb 23, 2026
Buy
Common Shares
M-Exempt
Torti Frank
President And Vant Chair
CEO / President 587 390
Value: $2.26M
Feb 23, 2026
Sell
Common Shares
S-Sale
Torti Frank
President And Vant Chair
CEO / President 587 390
Value: $16.2M
Feb 20, 2026
Sell
Common Shares
F-InKind
Pulik Richard
CFO
C-Suite Officer 1 000
Value: $27.2K
Feb 20, 2026
Sell
Common Shares
F-InKind
Venker Eric
President & Immunovant CEO
CEO / President 7 051
Value: $191.4K
Feb 20, 2026
Buy
Common Shares
M-Exempt
Torti Frank
President And Vant Chair
CEO / President 1 012 610
Value: $3.90M
Feb 20, 2026
Sell
Common Shares
S-Sale
Torti Frank
President And Vant Chair
CEO / President 1 012 610
Value: $27.5M
Feb 20, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Torti Frank
President And Vant Chair
CEO / President 1 012 610
Value: $3.90M
Feb 19, 2026
Buy
Common Shares
M-Exempt
Torti Frank
President And Vant Chair
CEO / President 1 400 000
Value: $5.39M
Feb 19, 2026
Sell
Common Shares
S-Sale
Torti Frank
President And Vant Chair
CEO / President 1 400 000
Value: $38.4M
Feb 19, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Torti Frank
President And Vant Chair
CEO / President 1 400 000
Value: $5.39M
Feb 13, 2026
Buy
Common Shares
M-Exempt
Venker Eric
President & Immunovant CEO
CEO / President 200 000
Value: $770.0K
Feb 13, 2026
Sell
Common Shares
S-Sale
Venker Eric
President & Immunovant CEO
CEO / President 200 000
Value: $5.30M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ROIVANT SCIENCES LTD.
Roivant Sciences
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aur...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE